FindMyRecallSubscribe
Class I: serious health riskTerminated

Pfizer diphenoxylate hydrochloride and atropine Recall

diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2

Pfizer Inc. · New York, NY

Risk level
Class I
Reported by FDA
Jan 10, 2018
Recall ID
D-0150-2018
Check your lot numberHow we source this data

Summary

Pfizer recalled diphenoxylate hydrochloride and atropine starting Oct 20, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-0150-2018 on Jan 10, 2018. Reason: SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent. Status: Terminated.

Why it was recalled

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Product description

diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977

Lot numbers, UPCs & expiration codes

Lots: a) R83962, R93347, R93348, R93349, R93350, R93351, R93352, Exp. 2021 OCT 31; S57831, S57832, S57834, Exp. 2021 NOV 30 b) R93356, R93357, R93358, R97310, Exp. 2021 OCT 31.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0150-2018
Classification
Class I
Status
Terminated
Recall initiated
Oct 20, 2017
FDA report date
Jan 10, 2018
Quantity
183437 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-0150-2018, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
78332
Address
235 E 42nd St
Code information
Lots: a) R83962, R93347, R93348, R93349, R93350, R93351, R93352, Exp. 2021 OCT 31; S57831, S57832, S57834, Exp. 2021 NOV 30 b) R93356, R93357, R93358, R97310, Exp. 2021 OCT 31.
Postal code
10017-5703
Report date
Jan 10, 2018
Product type
Drugs
Recall number
D-0150-2018
Classification
Class I
Recalling firm
Pfizer Inc.
Product quantity
183437 bottles
Termination date
Jun 2, 2020
Reason for recall
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Voluntary / mandated
Voluntary: Firm initiated
Product description
diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 20, 2017
Initial firm notification
Letter
Center classification date
Jan 4, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0150-2018, published Jan 10, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls